Aguareles, José
Forné, Carles
García-Casas, Ana
Santamaría-Corral, Guillermo
Carnevali-Ruiz, Daniel
Sotres-Fernández, Gabriel
Solera, Javier T
Guisado-Vasco, Pablo
Article History
Received: 17 January 2025
Accepted: 17 April 2025
First Online: 8 May 2025
Declarations
:
: Ethical approval was not required as the work consists of a post hoc analysis of published data.
: Not applicable.
: José Aguareles received meeting grant from PharmaMar SA and served as a scientific consultant. Carles Forné (Heorfy Consulting) has received fees from Hospital Universitario Quirónsalud Madrid for statistical analysis. Pablo Guisado-Vasco received speaker fees from FLS Science, PharmaMar SA (Madrid, Spain) and GlaxoSmithKline (Spain); consulting fees from Angelini Pharma and PharmaMar SA; served as an advisory board member for Berlin Cures GmbH and PharmaMar SA; and meeting grants from GlaxoSmithKline and PharmaMar SA. All remaining authors have declared no conflicts of interest.